Mayo Clinic Proceedings Home

Repeat Coronary Bypass Surgery or Percutaneous Coronary Intervention After Previous Surgical Revascularization



      To assess long-term survival with repeat coronary artery bypass grafting (RCABG) or percutaneous coronary intervention (PCI) in patients with previous CABG.


      From January 1, 2000, through December 31, 2013, 1612 Mayo Clinic patients underwent RCABG (n=215) or PCI (n=1397) after previous CABG. The RCABG cohort was grouped by use of saphenous vein grafts only (n=75), or with additional arterial grafts (n=140); the PCI cohort by, bare metal stents (BMS; n=628), or drug-eluting stents (DES; n=769), and by the treated target into native coronary artery (n=943), bypass grafts only (n=338), or both (n=116). Multivariable regression and propensity score analysis (n=280 matched patients) were used.


      In multivariable analysis, the 30-day mortality was increased in RCABG versus PCI patients (hazard ratio [HR], 5.32; 95%CI, 2.34-12.08; P<.001), but overall survival after 30 days improved with RCABG (HR, 0.72; 95% CI, 0.55-0.94; P=.01). Internal mammary arteries were used in 61% (129 of 215) of previous CABG patients and improved survival (HR, 0.82; 95% CI, 0.69-0.98; P=.03). Patients treated with drug-eluting stent had better 10-year survival (HR, 0.74; 95% CI, 0.59-0.91; P=.001) than those with bare metal stent alone. In matched patients, RCABG had improved late survival over PCI: 48% vs 33% (HR, 0.57; 95% CI, 0.35-0.91; P=.02). Compared with RCABG, patients with PCI involving bypass grafts (n=60) had increased late mortality (HR, 1.62; 95% CI, 1.10-2.37; P=.01), whereas those having PCI of native coronary arteries (n=80) did not (HR, 1.09; 95% CI, 0.75-1.59; P=.65).


      RCABG is associated with improved long-term survival after previous CABG, especially compared with PCI involving bypass grafts.

      Abbreviations and Acronyms:

      BMS (bare metal stent), CABG (coronary bypass grafting), DES (drug eluting stent), HR (hazard ratio), IMA (internal mammary artery), PCI (percutaneous coronary intervention), RCABG (repeat coronary artery bypass grafting), SVG (saphenous vein graft)
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Mayo Clinic Proceedings
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Weintraub W.S.
        • Jones E.L.
        • Craver J.M.
        • Grosswald R.
        • Guyton R.A.
        In-hospital and long-term outcome after reoperative coronary artery bypass graft surgery.
        Circulation. 1995; 92: 50-57
        • Sabik 3rd, J.F.
        • Blackstone E.H.
        • Houghtaling P.L.
        • Walts P.A.
        • Lytle B.W.
        Is reoperation still a risk factor in coronary artery bypass surgery?.
        Ann Thorac Surg. 2005; 80: 1719-1727
        • Tector A.
        Invited commentary.
        Ann Thorac Surg. 2009; 87: 1391
        • Fosbol E.L.
        • Zhao Y.
        • Shahian D.M.
        • Grover F.L.
        • Edwards F.H.
        • Peterson E.D.
        Repeat coronary revascularization after coronary artery bypass surgery in older adults: The Society of Thoracic Surgeons’ national experience 1991–2007.
        Circulation. 2013; 127: 1656-1663
        • Brilakis E.S.
        • Rao S.V.
        • Banerjee S.
        • et al.
        Percutaneous coronary intervention in native arteries versus bypass grafts in prior coronary artery bypass grafting patients: a report from the National Cardiovascular Data Registry.
        J Am Coll Cardiol Int. 2011; 4: 844-850
        • Spiliotopoulos K.
        • Maganti M.
        • Brister S.
        • Rao V.
        Changing pattern of reoperative coronary artery bypass grafting: a 20-year study.
        Ann Thorac Surg. 2011; 92: 40-46
        • Yap C.H.
        • Sposato L.
        • Akowuah E.
        • et al.
        Contemporary results show repeat coronary artery bypass grafting remains a risk factor for operative mortality.
        Ann Thorac Surg. 2009; 87: 1386-1391
        • Windecker S.
        • Kolh P.
        • et al.
        • Authors/Task Force members
        2014 ESC/EACTS guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI).
        Eur Heart J. 2014; 35: 2541-2619
        • Hillis L.D.
        • Smith P.K.
        • Anderson J.L.
        • et al.
        2011 ACCF/AHA guideline for coronary artery bypass graft surgery, executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
        Circulation. 2011; 124: 2610-2642
        • Akins C.W.
        • Buckley M.J.
        • Daggett W.M.
        • et al.
        Reoperative coronary grafting: changing patient profiles, operative indications, techniques, and results.
        Ann Thorac Surg. 1994; 58 (discussion 364-365): 359-364
        • Loop F.D.
        • Thurer R.L.
        • Lytle B.W.
        • Cosgrove D.M.
        Reoperation for myocardial revascularization.
        World J Surg. 1978; 2: 719-727
        • Schaff H.V.
        • Orszulak T.A.
        • Gersh B.J.
        • et al.
        The morbidity and mortality of reoperation for coronary artery disease and analysis of late results with use of actuarial estimate of event-free interval.
        J Thorac Cardiovasc Surg. 1983; 85: 508-515
        • Loop F.D.
        • Lytle B.W.
        • Cosgrove D.M.
        • et al.
        Reoperation for coronary atherosclerosis: changing practice in 2509 consecutive patients.
        Ann Surg. 1990; 212: 378-386
        • Cole J.H.
        • Jones E.L.
        • Craver J.M.
        • et al.
        Outcomes of repeat revascularization in diabetic patients with prior coronary surgery.
        J Am Coll Cardiol. 2002; 40: 1968-1975
        • Stephan W.J.
        • O’Keefe Jr., J.H.
        • Piehler J.M.
        • et al.
        Coronary angioplasty versus repeat coronary artery bypass grafting for patients with previous bypass surgery.
        J Am Coll Cardiol. 1996; 28: 1140-1146
        • Weintraub W.S.
        • Jones E.L.
        • Morris D.C.
        • King 3rd, S.B.
        • Guyton R.A.
        • Craver J.M.
        Outcome of reoperative coronary bypass surgery versus coronary angioplasty after previous bypass surgery.
        Circulation. 1997; 95: 868-877
        • Brener S.J.
        • Lytle B.W.
        • Casserly I.P.
        • Ellis S.G.
        • Topol E.J.
        • Lauer M.S.
        Predictors of revascularization method and long-term outcome of percutaneous coronary intervention or repeat coronary bypass surgery in patients with multivessel coronary disease and previous coronary bypass surgery.
        Eur Heart J. 2006; 27: 413-418
        • Brilakis E.S.
        • O’Donnell C.I.
        • Penny W.
        • et al.
        Percutaneous coronary intervention in native coronary arteries versus bypass grafts in patients with prior coronary artery bypass graft surgery: insights from the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program.
        J Am Coll Cardiol Int. 2016; 9: 884-893
        • Brilakis E.S.
        • Edson R.
        • Bhatt D.L.
        • et al.
        Drug-eluting stents versus bare-metal stents in saphenous vein grafts: a double blind, randomized trial.
        Lancet. 2018; 391: 1997-2007
        • Colleran R.
        • Kufner S.
        • Mehilli J.
        • et al.
        Efficacy over time with drug-eluting stents in saphenous vein graft lesions.
        J Am Coll Cardiol. 2018; 71: 1973-1982
        • Testa L.
        • Agostoni P.
        • Vermeersch P.
        • et al.
        Drug eluting stents versus bare metal stents in the treatment of saphenous vein graft disease: a systematic review and meta-analysis.
        EuroIntervention. 2010; 6: 527-536
        • Vermeersch P.
        • Agostoni P.
        • Verheye S.
        • et al.
        Increased late mortality after sirolimus-eluting stents versus bare-metal stents in diseased saphenous vein grafts: results from the randomized DELAYED RRISC Trial.
        J Am Coll Cardiol. 2007; 50: 261-267
        • Aggarwal V.
        • Stanislawski M.A.
        • Maddox T.M.
        • et al.
        Safety and effectiveness of drug-eluting versus bare-metal stents in saphenous vein bypass graft percutaneous coronary interventions: insights from the Veterans Affairs CART Program.
        J Am Coll Cardiol. 2014; 64: 1825-1836
        • Subramanian S.
        • Sabik 3rd, J.F.
        • Houghtaling P.L.
        • Nowicki E.R.
        • Blackstone E.H.
        • Lytle B.W.
        Decision-making for patients with patent left internal thoracic artery grafts to left anterior descending.
        Ann Thorac Surg. 2009; 87 (discussion 1400): 1392-1398
        • Morrison D.A.
        • Sethi G.
        • Sacks J.
        • et al.
        Percutaneous coronary intervention versus repeat bypass surgery for patients with medically refractory myocardial ischemia: AWESOME randomized trial and registry experience with post-CABG patients.
        J Am Coll Cardiol. 2002; 40: 1951-1954
        • Di Mauro M.
        • Iaco A.L.
        • Contini M.
        • et al.
        Reoperative coronary artery bypass grafting: analysis of early and late outcomes.
        Ann Thorac Surg. 2005; 79: 81-87
        • Xu B.
        • Yang Y.J.
        • Han Y.L.
        • et al.
        Validation of residual SYNTAX score with second-generation drug-eluting stents: one-year results from the prospective multicentre SEEDS study.
        Eurointervention. 2014; 10: 65-73
        • Azzalini L.
        • Candilio L.
        • Ojeda S.
        • et al.
        Impact of incomplete revascularization on long-term outcomes following chronic total occlusion percutaneous coronary intervention.
        Am J Cardiol. 2018; 121: 1138-1148
        • Antoniades C.
        • Bakogiannis C.
        • Tousoulis D.
        • et al.
        Preoperative atorvastatin treatment in CABG patients rapidly improves vein graft redox state by inhibition of Rac1 and NADPH-oxidase activity.
        Circulation. 2010; 122: S66-S73
        • Arsalan M.
        • Mack M.J.
        Coronary artery bypass grafting is currently underutilized.
        Circulation. 2016; 133: 1036-1045